CTOs on the Move

Implanet

www.implanet.com

 
Founded in 2007 and based near Bordeaux, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.implanet.com
  • Inc. 60 State Street Suite 700
    Boston, MA USA 02109
  • Phone: N/A

Executives

Name Title Contact Details

Similar Companies

Eckert and Ziegler Isotope Products (EZIP)

Eckert and Ziegler Isotope Products (EZIP) is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

RMC Research

RMC Research Corp. is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oasis Medical

Oasis Medical is a Glendora, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Musculoskeletal Clinical Regulatory Advisers

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client`s industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA`s integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.